Department of Gastroenterology, Galilee Medical Center, Faculty of Medicine in the Galilee, Bar-Ilan University, Nahariya 2221006, Israel.
Department of Endoscopy Unit, Private Hospital Jean Mermoz, Ramsay Generale de Sante, Lyon 69008, France.
World J Gastroenterol. 2022 Jan 21;28(3):332-347. doi: 10.3748/wjg.v28.i3.332.
The impressive technological advances in recent years have rapidly translated into the shift of endoscopic ultrasound (EUS) from diagnostic modality into an interventional and therapeutic tool. Despite the great advance in its diagnosis, the majority of pancreatic adenocarcinoma cases are inoperable when diagnosed, thus demanding alternative optional therapies. EUS has emerged as an easy, minimally invasive modality targeting this carcinoma with different interventions that have been reported recently. In this review we summarize the evolving role of interventional therapeutic EUS in pancreatic adenocarcinoma management.
近年来，令人印象深刻的技术进步迅速将内镜超声（EUS）从诊断方式转变为一种介入和治疗工具。尽管在诊断方面取得了巨大进步，但大多数胰腺腺癌病例在诊断时仍无法手术，因此需要替代的可选治疗方法。EUS 已成为一种针对这种癌症的简便、微创方式，最近报道了不同的干预措施。在这篇综述中，我们总结了介入治疗性 EUS 在胰腺腺癌治疗管理中的不断发展的作用。
